Medical News

RSS

Neuroimaging markers have synergistic effect on cognitive decline

The Alzheimer disease neuroimaging markers β-amyloid and neurodegeneration have synergistic effects on the rate of cognitive decline in clinically normal people, research shows.

2 Dec 2014

Initial relapsing phase hastens postprogression MS disability

Patients in the progressive phase of multiple sclerosis have a faster decline towards disability if they previously had a clinical relapsing phase, say researchers.

2 Dec 2014

‘Landmark’ study confirms aetiology effect on epilepsy mortality risk

A “landmark” meta-analysis confirms the increased mortality risk in patients who have symptomatic or cryptogenic epilepsy.

2 Dec 2014

BWH researchers identify cells responsible for fibrosis

Researchers from Brigham and Women's Hospital have identified what they believe to be the cells responsible for fibrosis, the buildup of scar tissue. Fibrotic diseases, such as chronic kidney disease and failure, lung disease, heart failure and cirrhosis of the liver, are estimated to be responsible for up to 45 percent of deaths in the developed world.

2 Dec 2014

Monash University, 60P Australia partner to develop Fenretinide drug for dengue fever

Monash University and 60P Australia Pty Ltd, a subsidiary of 60° Pharmaceuticals LLC, have announced today an exclusive partnering deal, with 60P obtaining rights to develop the drug Fenretinide for dengue fever.

2 Dec 2014

Perrigo receives final FDA approval for diclofenac sodium topical solution 1.5% w/w

Perrigo Company plc today announced that it has received final approval from the U.S. Food and Drug Administration on its Abbreviated New Drug Application (ANDA) for diclofenac sodium topical solution 1.5% w/w. Shipments to our pharmacy customers have commenced.

2 Dec 2014

Benvenue Medical's Luna 360 System receives FDA clearance for spinal fusion treatment of DDD

Benvenue Medical, Inc., a developer of minimally invasive solutions for spine repair, today announced that the company's Luna 360 Interbody Fusion System has received 510(k) clearance from the U.S. Food and Drug Administration for spinal fusion treatment of symptomatic degenerative disc disease (DDD).

2 Dec 2014

Press Ganey announces launch of Child HCAHPS survey solution

Press Ganey today announced the launch of its Child Hospital Consumer Assessment of Healthcare Providers and Systems Hospital Survey (Child HCAHPS) survey solution, complementing the company's Inpatient Pediatric solution and expanding its portfolio of industry-leading CAHPS solutions.

2 Dec 2014

Real-time surgical guidance study to evaluate TriVersa NanoMate with LESA capability from Advion

Advion, Inc. announces that is its TriVersa NanoMate with liquid extraction surface analysis (LESA) capability will be evaluated as part of a study at Brigham and Women’s Hospital.

From Advion 2 Dec 2014

BioPharmX submits request for pre-IND meeting to FDA for topical antibiotic acne compound

BioPharmX Corporation, a biotechnology company focused on the development of novel drug delivery products to address unmet needs in large, well-defined and underserved markets, today announced that it has submitted a request for a pre-IND (Investigational New Drug) meeting to the U.S. Food and Drug Administration for the company's topical antibiotic acne compound currently under development.

2 Dec 2014

EU-designed forecasting model developed to predict spread of Ebola

Forecasters predicting the spread of Ebola are using one of the most sophisticated modeling systems in the world - the result of an EU research project.

2 Dec 2014

Study examines rate of psychotropic medication prescribed to children in Kentucky

Researchers with the Child and Adolescent Health Research Design and Support Unit (CAHRDS Unit) at the University of Louisville have begun a study to examine one of Kentucky's most vexing children's health issues: the higher-than-average rate of psychotropic medication being prescribed to children in the Bluegrass State.

2 Dec 2014

BIOREM receives patent for innovative biological air purification media

BIOREM Inc.("Biorem" or "the Company") today announced that it has received a patent (US 8,772,015 B2) for its innovative biological air purification media.

2 Dec 2014

GlySure awarded three U.S. patents for proprietary calibration technique, sensor membrane

GlySure Limited, developer of in-hospital continuous blood glucose monitoring (CBGM) systems, announced today that it has been awarded three U.S. patents covering the company's core proprietary calibration technique and sensor membrane.

2 Dec 2014

Griffith University-hosted symposium to focus on issues surrounding implementation of NDIS

Two international experts in the field of human services and disability will partner with Griffith University for a symposium ahead of the roll-out of the National Disability Insurance Scheme (NDIS) in Queensland.

2 Dec 2014

AcelRx Pharmaceuticals' Zalviso device gets CE Mark approval

AcelRx Pharmaceuticals, Inc., a specialty pharmaceutical company focused on the development and commercialization of innovative therapies for the treatment of acute and breakthrough pain today announced that it has received CE Mark approval (Conformite Europeenne) for the Zalviso device.

2 Dec 2014

New educational initiative aims to help health professionals improve adverse event reporting

A new educational initiative by NPS MedicineWise and the Therapeutic Goods Administration (TGA) aims to improve both the quality and quantity of adverse event reporting relating to medicines, vaccines and medical devices to the TGA.

2 Dec 2014

IRIDEX's China distributor secures large tender to supply ophthalmology laser equipment

IRIDEX Corporation (Nasdaq: IRIX) announced today that its China distributor has been awarded a competitive tender for more than $620,000 in ophthalmology laser equipment to fulfill a government program designed to provide advanced ophthalmology solutions to patients across vast areas of China's rural regions.

2 Dec 2014

Oncolytics Biotech submits Orphan Drug Designation for pancreatic, ovarian cancers

Oncolytics Biotech Inc. ("Oncolytics") (TSX:ONC, NASDAQ: ONCY) today announced that it has submitted applications for Orphan Drug Designation to the U.S. Food and Drug Administration ("FDA") for REOLYSIN® for the treatment of pancreatic and ovarian cancers.

2 Dec 2014

New IDF guidelines can serve as valuable resource for studying heat resistance of bacteria

Using a common methodology to measure heat resistance of bacteria is crucial, so that the results of different studies can be compared.

2 Dec 2014

Medical News

Neuroimaging markers have synergistic effect on cognitive decline

Initial relapsing phase hastens postprogression MS disability

‘Landmark’ study confirms aetiology effect on epilepsy mortality risk

BWH researchers identify cells responsible for fibrosis

Monash University, 60P Australia partner to develop Fenretinide drug for dengue fever

Perrigo receives final FDA approval for diclofenac sodium topical solution 1.5% w/w

Benvenue Medical's Luna 360 System receives FDA clearance for spinal fusion treatment of DDD

Press Ganey announces launch of Child HCAHPS survey solution

Real-time surgical guidance study to evaluate TriVersa NanoMate with LESA capability from Advion

BioPharmX submits request for pre-IND meeting to FDA for topical antibiotic acne compound

EU-designed forecasting model developed to predict spread of Ebola

Study examines rate of psychotropic medication prescribed to children in Kentucky

BIOREM receives patent for innovative biological air purification media

GlySure awarded three U.S. patents for proprietary calibration technique, sensor membrane

Griffith University-hosted symposium to focus on issues surrounding implementation of NDIS

AcelRx Pharmaceuticals' Zalviso device gets CE Mark approval

New educational initiative aims to help health professionals improve adverse event reporting

IRIDEX's China distributor secures large tender to supply ophthalmology laser equipment

Oncolytics Biotech submits Orphan Drug Designation for pancreatic, ovarian cancers

New IDF guidelines can serve as valuable resource for studying heat resistance of bacteria

Lab Matters host Harriet Gould on building a more connected lab community

The Critical Role of Sample Storage in Drug Discovery and Development

Advancing Neuroscience Research Through Collaboration and Patient-Centered Innovation

Latest News